Immunological Medicines for Pigs
Immunological veterinary medicinal products, including vaccines, are authorised for pigs.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
Zylexis
|
Paramunisierung, Stimulierung unspezifischer Immunmechanismen
|
Zoetis Deutschland GmbH
|
PEI.V.02388.01.1 |
05.11.2001 |
Hund, Katze, Pferd, Rind, Schwein |
PharmNet.Bund
|
Aftopur DOE
|
Maul- und Klauenseuche
|
Boehringer Ingelheim Vetmedica GmbH
|
BFAV-B 367 |
17.12.2003 |
Rind, Schaf, Ziege, Schwein |
PharmNet.Bund
|
Porcilis Lawsonia ID
|
Lawsonia intracellularis-Infektion
|
Intervet Deutschland GmbH
|
PEI.V.12022.01.1 |
04.01.2021 |
Schwein |
|
Covexin 8
|
Enterotoxämie,
Rauschbrand,
Pararauschbrand,
Deutsche Bradsot,
Tetanus,
Infektiöse Hämoglobinurie
|
Zoetis Deutschland GmbH
|
A263/79 |
24.10.2005 |
Rind, Schaf, Schwein |
PharmNet.Bund
|
Enteroporc Coli AC
|
E. coli-Infektion, Clostridien-Infektion
|
CEVA Santé Animale
|
EU/2/20/262/001-004 |
09.12.2020 |
Schwein |
EPAR: Enteroporc Coli AC
|
PESTIPORC ORAL
|
Klassische Schweinepest
|
Ceva Tiergesundheit GmbH
|
FLI-B 363 |
23.02.2005 |
Schwein |
PharmNet.Bund
|
BIOSUIS Salm
|
Salmonellen-Infektion
|
Bioveta, a.s., Tschechien
|
PEI.V.11984.01.1 |
23.08.2019 |
Schwein |
PharmNet.Bund
|
Pestiffa CL
|
Klassische Schweinepest
|
Boehringer Ingelheim Vetmedica GmbH
|
ESP-L 4/84 |
09.12.2019 |
Schwein |
PharmNet.Bund
|
PESTIPORC
|
Klassische Schweinepest
|
Ceva Tiergesundheit GmbH
|
ESP-L 1/91 |
10.10.2008 |
Schwein |
PharmNet.Bund
|
Aftovaxpur DOE
|
Maul- und Klauenseuche
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/13/153/001-850 |
15.07.2013 |
Rind, Schaf, Schwein |
EPAR: Aftovaxpur DOE
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.